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An analysis of 79 yellow fever virus (YFV) isolates
collected from 1935 to 2001 in Brazil showed a single
genotype (South America I) circulating in the country, with
the exception of a single strain from Rondônia, which rep-
resented South America genotype II. Brazilian YFV strains
have diverged into two clades; an older clade appears to
have become extinct and another has become the domi-
nant lineage in recent years. Pairwise nucleotide diversity
between strains ranged from 0% to 7.4%, while amino acid
divergence ranged from 0% to 4.6%. Phylogenetic analy-
sis indicated traffic of virus variants through large geo-
graphic areas and suggested that migration of infected
people may be an important mechanism of virus dispersal.
Isolation of vaccine virus from a patient with a fatal case
suggests that vaccine-related illness may have been mis-
diagnosed in the past.
Y
ellow fever virus (YFV) is transmitted by the bite of
infected mosquitoes and produces a severe hemor-
rhagic fever in humans. Despite a safe and effective vaccine
(17D), YFVcontinues to be a public health problem in trop-
ical areas of Africa and South America (1–3). A recent
upsurge in YFV activity in Brazil and the reinfestation of
urban areas with the vector mosquito Aedes aegypti have
stretched disease surveillance and control resources to their
limits. During 2000, YFV occurred near Brasilia, the capi-
tal city (4); in 2001, YFV spread to new areas of Minas
Gerais outside the currently recognized enzootic zone (5). 
In South America, YFV is maintained in enzootic
cycles involving monkeys and forest-canopy mosquitoes
of the genera Haemagogus and Sabethes (6,7). In Brazil,
three geographic zones have been defined where YFV cir-
culates (7) (Figure 1): 1) the region of endemicity, in which
the virus is maintained in mobile monkey populations and
where human cases are sporadic and rare; 2) transitional
zones of emergence, in which contact is frequent between
monkey and human populations (and infected mosquito
vectors); and 3) regions of epidemicity where the density
of susceptible human populations and competent vector
species are both high, and the potential for explosive urban
outbreaks is great. Brazil currently has a population of
about 176 million; approximately 30 million people live in
the YFV-endemic zone, 18 million live in the zone of
emergence, and 128 million reside along the Atlantic coast
in the YFV-free zone (8,9). 
Many aspects of the molecular epidemiology and trans-
mission cycles of YFV in the forests of South America are
poorly understood, and previous studies of YFV in South
America were limited to a relatively small number of iso-
lates. We examined the genetic diversity of 79 YFV strains
isolated from Brazil over 67 years and mapped the distri-
bution of variants to investigate patterns of virus diver-
gence and dispersal. 
Material and Methods
Study Area
Brazil is a country of enormous size and diversity, cov-
ering 8,512,000 km2. The country is divided into 26 states
and the Federal District. These make up five major geo-
graphic regions, characterized by broadly different climate
and vegetation zones and a highly variable distribution of
the human population. The five regions (Figure 1) consist
of the northern Amazon region, northeastern region
(caatinga, very dry), central-western region (swamp and
savannah), southeastern region (most heavily populated
with an extensive system of roads and railways), and the
more temperate southern region bordering Argentina and
Paraguay (10).
Virus Strains 
Strain-specific data such as geographic locality,
passage history, source of isolate, and clinical outcome (for
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used in this study are provided in the online Appendix
(http://www.cdc.gov/ncidod/eid/vol10no9/04-
0197_app.htm). All strains were originally isolated in
suckling mice and cultured once in C6/36 cells to produce
seed stocks (online Appendix) at the Instituto Evandro
Chagas (IEC), Belém, Brazil. Methods for cell culture and
virus growth have been previously described (11–13), and
standard laboratory precautions within biosafety level 3
facilities were undertaken to prevent cross-contamination
of strains. Thirty-eight (48%) virus strains were from
humans (24 from patients who died); 7 (9%) were from
monkeys; and 34 (43%) were from mosquito pools,
mainly Haemagogus janthinomys. Viruses represented a
period of 67 years, but with unequal sample distribution:
15% of strains were obtained from 1935 to 1969, 43%
were obtained from 1970 to 1989, and 42% were obtained
from 1990 to 2001. The year of virus isolation is indicated
in the sequence identification (e.g., Brazil35, isolated in
1935). Isolates were from 12 states: Amapá (n = 1), Bahia
(n = 1), Federal District (n = 1), Goiás  (n = 10), Maranhão
(n = 6), Minas Gerais (n = 7), Mato Grosso (n = 4), Mato
Grosso do Sul (n = 5), Pará (n = 39), Rondônia (n = 2),
Roraima (n = 1), and Tocantins (n = 2). 
Phylogenetic Analysis
Supernatants of YFV-infected Vero cells were obtained,
and viral RNA was extracted by using a commercial kit
(Qiagen, Valencia, CA) and processed according to the
manufacturer’s instructions. RNA obtained was stored at
–70oC. The genomic-sense degenerate primer EMF (5′
TGGATGACSACKGARGAYAT) and genomic-comple-
mentary primer VD8 (5′ GGGTCTCCTCTAACCTCTAG)
were used for reverse transcription–polymerase chain
reaction amplification of a 595-bp fragment comprising
255 nucleotides of NS5 and 340 nucleotides of 3′NCR
(14,15). PCR products were screened by agarose gel elec-
trophoresis. Bands were recovered with a gel extraction kit
(Qiagen) and directly sequenced with an ABI automatic
sequencer at the University of Texas Medical Branch pro-
tein chemistry core facility.
Sequence editing and alignments were performed with
Vector NTI (Informax, Frederick, MD), and additional
manual editing of alignments was performed with the
GCG Wisconsin Package Version 10.3 (Accelrys, San
Diego, CA). The PAUP* program (16) was used to infer
phylogenetic trees by the neighbor-joining method with
Kimura 2-parameter distance corrections. Support for indi-
vidual clades was determined by nonparametric bootstrap-
ping with 1,000 replicates. The tree was rooted with a
sequence of the prototype West African YFV strain Asibi
(17) and the 17DD substrain vaccine virus (18). 
Results
Genetic Diversity of Brazilian YFV Strains
Sequence data were obtained for a genomic region
spanning the terminal portion of NS5 and proximal region
of the 3′NCR for 54 Brazilian YFV strains. In addition to
the sequence data generated in this study, partial or com-
plete 3′NCR sequences were available for an additional 25
Brazilian YFV isolates (13,14), which yielded the full
dataset of 79 YFV strains from 12 states (alignment length,
576 nt). The NS5/3′NCR sequences contained 148 variable
sites, of which 89 were informative. Thirty-two of the
informative sites (36%) fell within the NS5 coding portion
of the sequence, and 57 (64%) fell within the 3′NCR.
Amino acid pairwise divergence among the partial NS5
sequences (85 amino acids in length) ranged from 0% to
4.7% (mean 2.2%). 
A phylogenetic tree of the 79 Brazilian YFV sequences
is shown in Figure 2. The tree is rooted with the homolo-
gous region of the Asibi prototype strain (parental virus to
the 17D vaccine), isolated in Ghana in 1927 (17).
Mosquito- and vertebrate-derived sequences were distrib-
uted randomly throughout the phylogenetic tree. With the
exception of one 1983 isolate from Rondônia (BeH
413820) and one 1975 isolate from Aripuana in Mato
Grosso (BeH 291597), all Brazilian YFV strains formed a
single monophyletic clade. Two major subclades were evi-
dent: a subclade comprising isolates from Pará dating from
1954 to1968 and a subclade containing all remaining iso-
lates from 1969 to 2001.
Variation within the Dominant Subclade
Genetic variation within the dominant subclade of
Brazilian YFV strains showed a complex pattern of rela-
tionships that demonstrated both geographic and temporal
associations. Varying levels of bootstrap support were evi-
dent for four clusters (groups 1A–1D) (Figure 2): group
1A included isolates from the 1972–1973 outbreak in
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Figure 1. Regions where yellow fever is endemic in Brazil.Goiás and a 1984 isolate from Pará, group 1B represented
sporadic human cases and samples obtained during routine
surveillance in western and central regions from 1984 to
1996, group 1C consisted of isolates from sporadic cases
and surveillance in eastern central states from 1971 to
1998, and group 1D represented epizootic activity from
1998 to 2001. The phylogenetic position of 12 additional
isolates from Pará (10), Amapá (1), and Mato Grosso (1)
was not easily resolved (Figure 2), so relationships among
these strains require further sequence analysis.
The four isolates from the 1972–1973 epidemic in
Goiás (group 1A, Brazil73a, 73b, 73c, and 73d) differed by
2–3 nt (0.34%–0.5%) over the length of the NS5/3′NCR
fragment (595 nt). One isolate obtained 11 years later
(Brazil84e) from a pool of Haemagogus janthinomys mos-
quitoes collected in far northern Pará (Faro), was nearly
identical to the 1973 Goiás strains (2–3 nt difference). 
Group 1B consisted of 11 isolates. These included two
isolates from patients who died (Brazil84h and Brazil91b),
isolates from patients in Mato Grosso do Sul (Brazil92c)
and Maranhão (Brazil93a), isolates from Haemagogus
mosquitoes in western Pará (Brazil84d) and Rondônia
(Brazil96a), and four isolates obtained in 1992 from mos-
quito pools (Brazil92a, 92b, 92d, and 92e). Although most
strains in group 1B were identified in western and central
regions (over a distance as large as 3,500 km2), one isolate
identified in this cluster was from the northeast region in
Barra do Corda, Maranhão (Brazil93a). Isolates collected
from contemporaneous Haemagogus and Sabethes mos-
quito pools (Brazil92a, 92b, 92d, and 92e) were 100%
identical. 
Group 1C formed the largest cluster, with 22 strains
diverging by 0% to 3.8% (0–27 nt, bootstrap 80%). These
variants were distributed during an extended period from
1971 to 1994 throughout the northern Amazon region
(Pará: Brazil87, 91a, 84c, 84g, 71, 78a, 84b, 94c, and 98a;
Maranhão: Brazil80c, 82a, 93b, 94f, and 95), in central
Goiás (Brazil88a, 80a, and 91c), and near the edge of the
enzootic zone in Minas Gerais (Brazil89, 88b, 94d, 94b,
and 94a). A pair of Minas Gerais isolates (Brazil94b and
94a) obtained from Haemagogus and Sabethes mosquito
pools showed a 100% match across the length of the
sequence fragment. 
With one exception (Brazil98a), all isolates collected
during 1998 to 2001 fell within a single cluster (group 1D)
that had 0%–2.7% (0–16 nt) divergence. Although group
1D consistently clustered on neighbor-joining and parsi-
mony trees, bootstrap support was low (53%). The distri-
bution of samples collected during this period closely
reflected the southward dispersal of epizootic activity. In
1998, a large number of YF cases occurred in northern
Brazil, especially in Pará. In 1999 through 2000, a few
cases were reported in Bahia and Tocantins, but the largest
number were in central Goiás (19). In 2001, YF cases were
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Figure 2. Brazilian NS5/3'NCR phy-
logeny (576 nt) based on yellow fever
isolates (neighbor-joining tree, Kimura
2-parameter distance correction, mid-
point rooted). Geographic origin of iso-
lates is indicated on map. 1: North (AC,
Acre; AM, Amazonas; AP, Amapá; PA,
Pará; RO, Rondônia; RR, Roraima; TO,
Tocantins). 2: Northeast (AL, Alagoas;
BA, Bahia; CE, Ceará; MA, Maranhão;
PB, Paraiba; PE, Pernambuco; PI,
Piaui; RN, Rio Grande do Norte; SE,
Sergipe). 3: Central West (DF, Distrito
Federal; GO, Goiás; MT, Mato Grosso;
MS, Mato Grosso do Sul). 4: Southeast
(ES, Espírito Santo; MG, Minas Gerais;
RJ, Rio de Janeiro; SP, São Paulo). 5:
South (PR, Paraná; SC, Santa
Catarina; RS, Rio Grande do Sul).
Colors correspond to genetic clade
structure. Black dots refer to isolates
with unresolved phylogenetic position.
To view a full-size version of this figure,
please visit www.cdc.gov/ncidod/eid/
vol10no9/04-0197-G2.htmdetected in the transitional zone of Minas Gerais and fur-
ther east. The isolate from Tocantins collected in 2000
(Brazil2000a) was characterized by an exceptionally large
number of substitutions in the 3′NCR region. A single iso-
late (Brazil98a) collected from a howler monkey in Afua,
Pará, during the early period of the epizootic did not clus-
ter with the other group 1D strains. 
Subclade of Older Pará Strains
A group of ten isolates from Pará dating from 1954
through 1968 differed from all other Brazilian strains by
5.7% ± 1.6%. These results confirmed previous observa-
tions based on analysis of prM/E gene sequences (14),
indicating 7.8% ± 2.0% divergence for this group of older
Pará isolates. To date, 29 YFV strains from Pará dating
from 1969 through 1999 have been examined; none of
these more recent strains cluster with the earlier clade.
Sequence divergence of the older Pará strains approached
the threshold level used to define separate YFV genotypes
(8%–9%) (20).
Alignment of previously published sequences for the
structural gene region (223 codons of prM/E) (14) showed
that 8 of the 10 older Pará strains had one or more muta-
tions within the fusion peptide of the E protein (Figure 3)
that is highly conserved among all flaviviruses; it is locat-
ed in domain II (E98–E110) and plays a role in mediating
the acid-catalyzed fusion of virions with target cell mem-
branes (22). Three strains from 1968 (Brazil68a, 68c, and
68d) showed a C→F substitution at E105, eliminating one
of the disulfide bonds that forms the structural architecture
of domain II (22). Brazil68b had a D→G mutation at E98,
and Brazil54 and Brazil68a shared an R→K mutation at
E99. Three of the strains (Brazil55c, Brazil60, Brazil62b)
had a G→S substitution at E100. The functional impor-
tance of these mutations is unknown. Of the older Pará
strains, only Brazil55b and Brazil62a had the consensus
sequence for the fusion peptide (Figure 3). In addition, 12
non-Pará subclade strains exhibited substitutions in the
fusion peptide sequence.
Preliminary phenotypic differences among three of the
older Pará strains (Brazil55b, Brazil60, and Brazil68c) in
the standard mouse neuroinvasiveness model (i.e.,
intraperitoneal injection of 8-day-old suckling mice) (23)
indicated that the strains with substitutions in the fusion
peptide were less lethal (average lethal dose-50 [LD50] for
Brazil60 and Brazil68c = 5.5 log10 tissue culture infective
dose-50 [TCID50]) than the strain with the consensus
sequence (Brazil55b) (LD50 = 0.1 log10 TCID50). Average
survival times of the infected mice were 9.2, 11, and 8.8
days, respectively, for the three strains. All three strains
achieved titers 6–7 log10 TCID50/mL when grown in Vero
cell culture. Brazil55b had a longer passage history than
other YFV strains (4 passages in suckling mouse brain)
(online Appendix); thus the altered phenotype may be part-
ly attributed to selection during repeated mouse passage.
Additional Brazilian Isolates 
Two Brazilian strains (Brazil83 from Rondônia and
Brazil75 from Mato Grosso) failed to group within either
of the two major subclades. Brazil83 appears to represent
South American genotype II, as it matched 97.2% to the
homologous NS5/3′NCR region of Peruvian YFV strains
(14) and diverged from other Brazilian strains by 6.2% to
13.8% (mean 10.2%). Brazil75 was a vaccine virus, as it
matched the 17DD vaccine virus by 99.8%. Sequence
comparison of 17DD with Brazil75 revealed a single muta-
tion (C→T) at position 16 of the 3′NCR (13). 
Discussion
Brazil accounts for approximately 25% of all YF cases
reported from South America (4). YFV activity has been
reported from each of the five regions in the country
(2,24). From 1950 to 2003, no single region consistently
produced the highest number of YF cases; however, YFV
activity in the dry northeast was rare (Figure 4). Overall,
the largest number of cases was reported from Goiás (cen-
tral-western) and Pará (northern) regions.
Previous studies of the genetic relationships among
global variants of YFV have indicated that divergence
across the length of the ≈11-kb genome is relatively uni-
form, and the 3′NCR contains useful markers for subtype-
specific distinctions (13,25). Our data showed a single
genotype of YFV circulating in Brazil (South American
genotype I), with the exception of a single strain from
Rondônia (South America genotype II). The Brazilian
strains made up two subclades: a group of older strains
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Figure 3.  Sequence alignment of the fusion peptide of the enve-
lope (E) gene of selected yellow fever virus (YFV) strains
(E98–E110). The Asibi prototype strain indicates the conserved
sequence present in the majority of YFV strains and other mos-
quitoborne flaviviruses. A salt bridge between residues Asp E98
and Lys E110 generates the “CD loop” of residues E100–E108
(21).from Pará from 1954 to 1968 and a larger group dating
from 1969 to the present. The clear genetic distinction
between strains isolated before 1968 (10 in total) and all
subsequent strains suggests that the older Pará strains have
been replaced by a dominant new lineage. Several mem-
bers of the older Pará subclade had one or more mutations
within the fusion peptide region of the E protein, including
substitutions that disrupted conserved disulfide bridges
(Figure 3). Although the functional importance of these
substitutions is unknown, changes in the fusion peptide
would affect protein folding and conformation and binding
interactions with target membranes (22). Continued sam-
pling and surveillance of YFV strains from Pará are neces-
sary to confirm whether the variants represented in this
subclade have truly become extinct or whether they are
being maintained in cycles that have yet to be identified. 
At least three articles in the past 50 years have reported
YFV epizootics that began in northern and western
Amazonian regions and then spread south into Paraná,
Santa Catarina, and Rio Grande do Sul. The first was a
large epidemic that swept south from Goiás in the 1930s
and 1940s (26). The second was in 1963, when an epi-
zootic started in Mato Grosso and extended eventually as
far south as Missiones and Corrientes Provinces in north-
ern Argentina by 1966 (27). In 1972 to 1973, an outbreak
occurred in Goiás, and although investigations at the time
suggested the epizootic was highly localized (28), cases
reported from Paraguay in the following years were attrib-
uted to spread of viruses from Goiás. Virus maintenance
and dispersal have presumably involved sequential infec-
tions of migrating groups of monkeys (29–32). Four iso-
lates collected during the 1972–1973 Goiás outbreak were
included in this study; these isolates (group 1A,
Brazil73a–d) had nearly identical (99.6%) NS5/3′NCR
sequences, and a fifth isolate with a highly similar
sequence was obtained 10 years later from Faro, in north-
ern Pará. Other than the single Faro isolate (Brazil84e), no
additional descendents have been identified of those out-
break strains. 
YFV transmission was particularly active during the
rainy season in Maranhão in 1993 to 1994 (33). Serologic
studies of rural and urban populations at the time indicat-
ed an overall attack rate of 75 per 1,000; incidence of clin-
ical disease was 3.5 per 1,000 persons in urban areas and
4.2 per 1,000 in rural areas. Five of the six Maranhão iso-
lates from this time were in group 1C (Figure 2), whereas
one isolate from a patient with a fatal case (Brazil93a)
appeared to be related to group 1B (Figure 2). In addition
to the 1993–1994 outbreak in Maranhão, the subclade of
group 1C strains was also associated with sporadic cases
throughout 1971 to 1998 in Pará, Minas Gerais, and
Goiás.
The most recent increase in epizootic YFV activity in
Brazil occurred from 1998 to 2001, with cases distributed
over a large region covering eight states (4). Several
human cases were reported to have originated from the
Chapada dos Veadeiros National Park, a tourist canyon
located near Brasilia, Goiás. The proximity to major cities
raised alarm, and reports at the time designated Goiás as
the epicenter of the outbreak (4). The phylogenetic evi-
dence presented here indicates that YFV activity in 1998 in
Pará, in 2000 in Goiás, and in 2001 in Minas Gerais was
all part of one continuous epizootic, which dispersed
genetic variants from the 1D group of viruses (Figure 2). 
Investigations in 2000 and 2001 indicated that YFV
activity had expanded beyond the typical borders of the
enzootic zone, into areas where the virus had not been
reported for >100 years. The appearance of nearly identi-
cal variants across very large distances over short periods
(e.g., group 1D spanning >3,000 km within 1 month, group
1B strains with isolates >2,000 km apart within 1 year)
suggests that humans, rather than other primates or mos-
quitoes, may be partly responsible for the spread of YFV
variants. Because Haemagogus mosquitoes are forest
species and are relatively fragile, patterns of traffic and
commerce would not likely lead to translocation of infect-
ed mosquitoes. From 1998 to 2001, the virus may have
been transported from Pará (34) to Goiás (4) and then to
Minas Gerais by asymptomatic carriers or viremic persons
in the prodromal phase. The general trend in the southward
movement of the virus (group 1D, Figure 2) could be inter-
preted to reflect the pattern of labor migration from less
populated areas of the northern Amazon to cities of the
southeast. However, humans are not believed to play a
major role in either virus maintenance or dispersal within
South America, because human contact with the forest
species Haemagogus janthinomys is infrequent, and the
length of the viremic period in infected humans is brief
(3–4 days).
The identification of one strain from western Rondônia
(Brazil83) with high identity to South American genotype
II strains (from Peru and Bolivia) suggests that the two
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Figure 4. Yellow fever incidence in Brazil by region, 1950–2003.South American YFV genotypes cocirculate in regions of
western Brazil. The genetic divergence and distribution of
YFV are similar that of Oropouche virus (an
Orthobunyavirus transmitted by midges). Like YFV,
Oropouche virus has split into two distinct genotypes in
South America with separate eastern and western regions
of circulation, and the only region where the two geno-
types have been found to cocirculate is in western Brazil,
in Rondônia (35). The ecologic correlates for these pat-
terns remain uncertain; however, they suggest that surveys
of the border regions between Brazil, Peru, and Bolivia
may identify additional YFV genotypes.  
One unanticipated result of this study was identifying a
vaccine virus (Brazil75) from what had been presumed to
be a case of natural exposure to wild-type YFV. This iso-
late was obtained from the blood of a patient who died in
Aripuanã, Mato Grosso; this patient had been vaccinated 5
days before becoming ill and died 9 days postvaccination.
Serious adverse effects resembling wild-type YF (vis-
cerotropic disease) have only recently been reported
(19,36,37). The complete genomic sequence of Brazil75 is
currently being sought to address the question of vaccine
reversion. Although no controlled studies have examined
the safety or efficacy of YF vaccination in immunosup-
pressed patients, these findings underscore the importance
of evaluating patient history before delivering vaccine and
also suggest that other cases of vaccine-related illness may
have been misdiagnosed in the past. 
In summary, we describe considerable genetic variabil-
ity among YFV variants circulating in Brazil and identify
clusters of strains associated with epizootics in different
geographic regions. Brazilian YFV strains have diverged
into two subclades, one of which has become the dominant
lineage in recent years. We suggest a potential role for
human migration in mediating virus dispersal. Expansion
of YFV outside the enzootic zone presents an ongoing risk
for reintroduction of the virus to urban areas and highlights
the need for continued surveillance and control. 
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